KP Tissue Inc. (TSE:KPT - Get Free Report) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$11.99 and traded as high as C$12.94. KP Tissue shares last traded at C$12.72, with a volume of 18,947 shares trading hands.
Analysts Set New Price Targets
A number of research analysts recently weighed in on the company. Desjardins upped their price objective on KP Tissue from C$12.00 to C$12.50 and gave the stock a "hold" rating in a report on Friday, May 15th. TD raised their target price on KP Tissue from C$12.00 to C$14.00 and gave the company a "hold" rating in a report on Tuesday, July 14th. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of C$12.12.
Read Our Latest Stock Report on KP Tissue
KP Tissue Stock Down 0.6%
The business's fifty day moving average is C$12.97 and its 200 day moving average is C$11.99. The stock has a market cap of C$127.61 million, a PE ratio of 14.45, a P/E/G ratio of -0.88 and a beta of 0.53.
KP Tissue (TSE:KPT - Get Free Report) last issued its earnings results on Thursday, August 13th. The company reported C$0.24 earnings per share (EPS) for the quarter. As a group, analysts predict that KP Tissue Inc. will post 0.4398964 EPS for the current year.
KP Tissue Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 15th were paid a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 6.6%. The ex-dividend date of this dividend was Tuesday, June 30th. KP Tissue's dividend payout ratio (DPR) is presently 85.23%.
Insider Buying and Selling
In other KP Tissue news, Director David A. Spraley sold 3,668 shares of the business's stock in a transaction on Wednesday, June 17th. The stock was sold at an average price of C$13.30, for a total transaction of C$48,784.40. Following the sale, the director directly owned 15,712 shares in the company, valued at approximately C$208,969.60. The trade was a 18.93% decrease in their ownership of the stock. Insiders sold 6,668 shares of company stock worth $87,644 in the last quarter. 0.14% of the stock is currently owned by insiders.
KP Tissue Company Profile
(
Get Free Report)
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.